Clearmind Medicine Statistics
Total Valuation
CMND has a market cap or net worth of $2.70 million. The enterprise value is -$11.43 million.
| Market Cap | 2.70M |
| Enterprise Value | -11.43M |
Important Dates
The next estimated earnings date is Tuesday, October 6, 2026, after market close.
| Earnings Date | Oct 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CMND has 3.37 million shares outstanding. The number of shares has increased by 4,178.16% in one year.
| Current Share Class | 3.37M |
| Shares Outstanding | 3.37M |
| Shares Change (YoY) | +4,178.16% |
| Shares Change (QoQ) | +423.96% |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | 1.46% |
| Float | 3.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.13 |
| P/TBV Ratio | 0.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.31, with a Debt / Equity ratio of 0.14.
| Current Ratio | 4.31 |
| Quick Ratio | 4.28 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,196.98 |
Financial Efficiency
Return on equity (ROE) is -106.98% and return on invested capital (ROIC) is -69.96%.
| Return on Equity (ROE) | -106.98% |
| Return on Assets (ROA) | -53.08% |
| Return on Invested Capital (ROIC) | -69.96% |
| Return on Capital Employed (ROCE) | -67.93% |
| Weighted Average Cost of Capital (WACC) | -1.09% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CMND has paid $12,695 in taxes.
| Income Tax | 12,695 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.81% in the last 52 weeks. The beta is -1.14, so CMND's price volatility has been lower than the market average.
| Beta (5Y) | -1.14 |
| 52-Week Price Change | -99.81% |
| 50-Day Moving Average | 1.48 |
| 200-Day Moving Average | 9.17 |
| Relative Strength Index (RSI) | 28.32 |
| Average Volume (20 Days) | 1,168,292 |
Short Selling Information
The latest short interest is 25,174, so 0.75% of the outstanding shares have been sold short.
| Short Interest | 25,174 |
| Short Previous Month | 49,268 |
| Short % of Shares Out | 0.75% |
| Short % of Float | 0.75% |
| Short Ratio (days to cover) | 0.17 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.87M |
| Pretax Income | -7.48M |
| Net Income | -7.50M |
| EBITDA | -8.86M |
| EBIT | -8.87M |
| Earnings Per Share (EPS) | -$14.80 |
Balance Sheet
The company has $15.93 million in cash and $1.80 million in debt, with a net cash position of $14.13 million or $4.20 per share.
| Cash & Cash Equivalents | 15.93M |
| Total Debt | 1.80M |
| Net Cash | 14.13M |
| Net Cash Per Share | $4.20 |
| Equity (Book Value) | 12.95M |
| Book Value Per Share | 6.04 |
| Working Capital | 12.77M |
Cash Flow
| Operating Cash Flow | -7.07M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 10,954 |
| Net Borrowing | 10.08M |
| Free Cash Flow | -7.07M |
| FCF Per Share | -$2.10 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CMND does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4,178.16% |
| Shareholder Yield | -4,178.16% |
| Earnings Yield | -277.29% |
| FCF Yield | -261.46% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 21, 2026. It was a reverse split with a ratio of 1:10.
| Last Split Date | May 21, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |